Skip to content
‹ Back to IndustriesHealthcare

How Josh Byrd Uses Songwriting Experience to Tell the Patient Story

Like most marketers, Josh Byrd, VP of Marketing at Relatient, has many passions. Outside of his marketing work with Relatient, Byrd is a professional country music songwriter. And it’s this ability to tell a story in song that strengthens Byrd’s abilities as a marketer. Byrd joined David Kemp on the Highway to Health to talk…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI in a free MarketScale workspace. Qualifying companies also get one professional video edit a month. No credit card.

Start free

Like most marketers, Josh Byrd, VP of Marketing at Relatient, has many passions. Outside of his marketing work with Relatient, Byrd is a professional country music songwriter. And it’s this ability to tell a story in song that strengthens Byrd’s abilities as a marketer. Byrd joined David Kemp on the Highway to Health to talk about his love for marketing and how merging passions is a recipe for success.

“Good marketing is about connection,” Byrd said. “Whether you’re writing a song or a blog, or a podcast, or a white paper, or anything, you’re really searching for that emotional connection.”

Byrd began his journey by mixing his dream of country music fame with some paying marketing gigs. And never one to pass down an opportunity when it came his way, Bryd soon found marketing an offer he couldn’t refuse. New passions emerged, and he discovered working for startups was an exciting area to practice his marketing abilities. Articulating a startup’s story happened to be up Byrd’s ally. “It wasn’t all too different from a music journey, right? It’s helping somebody tell their story.”

Eventually, Byrd worked for a healthcare startup, helping patients understand the payment process better. And now, working at Relatient, Byrd gets to focus on patient engagement at an even deeper level. “We’re working on the scheduling and messaging side of things to make sure that patients are involved in their care from the get-go.”

There is no end to challenges in healthcare, but success is always a corner away with the right tools and guidance. Patient engagement is an area ripe for improvement, and it’s a rewarding challenge that Byrd said brings purpose and meaning to his work. “Last year, Relatient engaged with we 50 million patients. That’s 50 million opportunities to make someone’s life better.”

More Like This Story:

From an Idea to Billion Dollar Company: How a Doctor Lobbied DC for HSAs

Educating Customers Will Be Key to Balancing Customers Expectations With Healthcare Plans

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0. No credit card. Company confirmation required.

More Healthcare Insights

Medicare will pay up to $137.53 per case in 2027 for BriefCase‑Triage

Medicare will pay up to $137.53 per case in 2027 for BriefCase‑Triage

Radiology Business reported Medicare will pay a maximum of $137.53 per case in 2027 for BriefCase-Triage. Holland & Knight said hospitals will be eligible for NTAP reimbursement for use of Aidoc’s CARE Body CT Multi-Triage beginning Oct. 1, 2026, with supplemental payments continuing for three years.

  • 01Radiology Business reported Medicare will pay a maximum of $137.53 per case in 2027 for BriefCase-Triage.
  • 02Holland & Knight said CMS approved an NTAP designation for Aidoc’s CARE Body CT Multi-Triage, with hospitals eligible for NTAP reimbursement beginning Oct. 1, 2026, with supplemental payments continuing for three years.

Sep 23, 2026

Blair Health raises CAD $4.24M to expand its LLM-guided specialty care workflows

Blair Health raises CAD $4.24M to expand its LLM-guided specialty care workflows

Blair Health raised CAD $4.24 million in a pre-seed round, according to Fierce Healthcare. It plans to expand protocol-driven virtual specialty care across Canada and the U.S.

  • 01Blair Health raised CAD $4.24 million in pre-seed funding.
  • 02Qualified Health positions its AI platform around safety and governance, including clinician oversight, auditability and traceability, according to Fierce Healthcare.

Sep 23, 2026

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512